Datamonitor, June 2011, Pages: 94
F. Hoffmann-La Roche Ltd: PharmaVitae Profile Introduction
This analysis examines the historical and forecast performance for Roche in the prescription pharmaceutical sector. The profile encompasses
Datamonitor, July 2010, Pages: 117
F. Hoffmann-La Roche Ltd.: PharmaVitae Profile This analysis examines the historical and forecast performance for Roche in the prescription pharmaceutical sector. The profile encompasses global
Datamonitor, Nov 2010, Pages: 104
Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile Introduction
This analysis examines the historical and forecast performance for Chugai in the prescription pharmaceutical sector. The profile
Datamonitor, June 2010, Pages: 116
Bayer Schering Pharma AG: PharmaVitae Profile Introduction
This analysis examines the historical and forecast performance for Bayer Schering in the prescription pharma sector. The profile
Datamonitor, June 2010
Bayer AG: PharmaVitae Profile This analysis examines the historical and forecast performance for Bayer in the prescription pharmaceutical sector. The profile encompasses global company strategy
Datamonitor, Oct 2009, Pages: 113
Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile This analysis examines the historical and forecast performance for Chugai in the prescription pharmaceutical sector. The profile encompasses global
NeuroInsights, May 2011, Pages: 500+
The Neurotechnology Industry 2011 Report Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System: Market Analysis and Strategic Investment Guide of the Global
Datamonitor, Dec 2009, Pages: 114
company over the period 1995-2014
Chapter 1 Introduction
Scope of analysis
Methodology
Company coverage
Data sources
Re-creating analysis from this report using PharmaVitae Explorer queries
Further
Datamonitor, May 2011, Pages: 95
Genzyme Corporation This analysis examines the historical and forecast performance for Genzyme in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio
Datamonitor, March 2010, Pages: 114
Company classifications
Explanation of launch/core/expiry analysis
3. Licensing Trends Overview
Key findings
Big Pharma trends
Big Pharma's reliance on externally sourced products drives sales growth
Datamonitor, March 2009, Pages: 148
Genentech Inc.: PharmaVitae Profile This analysis examines the historical and forecast performance for Genentech in the Rx pharmaceutical sector. The profile encompasses global company strategy
NeuroInsights, May 2010
The Central Nervous Systems Market 2010 Report Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System: Market Analysis and Strategic Investment Guide of the Global
Global Markets Direct, Sep 2011, Pages: 87
. Hoffmann-La Roche Ltd.
Abbott Laboratories
Amgen Inc.
Eli Lilly and Company
Quark Pharmaceuticals, Inc.
Merck & Co., Inc.
MD Scientific, LLC
Astellas Pharma Inc.
Mitsubishi Tanabe
Espicom Business Intelligence Ltd, Oct 2009, Pages: 290
Subsidiaries and joint ventures - Adherex Technologies Inc
- Adolor Corporation
- Aeras Global TB Vaccine Foundation
- Antigenics Inc
- Aphton Corporation
- Asahi Chemical Industry Co
- Astellas Pharma
- AVANT
Datamonitor, June 2008, Pages: 363
of pipeline dynamics.
Scope
- Comprehensive financial strategic analysis of the mAb market out to 2013
- Global sales forecasts to 2013 for marketed and Phase III mAb products
- Analysis of market
